Browsing: Disease Area > Bacterial
To round up 2017, we asked our Expert panel to choose their top papers from the year. Here, you can discover these articles and the reasons why they were chosen.
Want to find out what’s been happening this year? Editor, Martha Powell, highlights the best of 2017’s infectious diseases research in an A–Z.
A newly-developed single-dose cholera vaccine has shown promise in clinical trials, suggesting it could provide faster protection and control outbreaks more rapidly than the standard regimen.
Researchers have demonstrated that facial cleanliness can be reliably measured, suggesting that this should be incorporated into surveys assessing trachoma control efforts.
Researchers have demonstrated that antibiotic-resistance plasmids persist in the absence of antibiotics, provided that the efficiency of plasmid transfer exceeds a critical threshold, highlighting the limitations of ‘resistance-reversal’ strategies.
In this article, carbapenem antimicrobial susceptibility testing profiles were determined in a population of Klebsiella pneumoniae, and their resistance assessed based on previous and current Clinical and Laboratory Standards Institute criteria.
Researchers have analyzed the microbiomes of flies, suggesting that these insects could have more disease-carrying potential than previously thought.
Nontuberculous mycobacteria (NTM) are increasingly recognized as important opportunistic pathogens of humans, the authors dicuss the clinical managment and treatments for nontuberculous mycobacterial infections.
Researchers have unveiled novel pathways controlled by the multiple antibiotic resistance operon and identified new ways in which bacteria protect themselves against antibiotics.